4//SEC Filing
Meyers Michael L. 4
Accession 0001562180-20-005074
CIK 0001395937other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:11 PM ET
Size
4.9 KB
Accession
0001562180-20-005074
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Award
Common Stock
2020-07-06+3,500→ 10,730 total
Footnotes (1)
- [F1]50% of the shares will vest on July 6, 2021 and the remaining 50% of the shares will vest on July 6, 2022.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001664204
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:11 PM ET
- Size
- 4.9 KB